Jacinda Tran
Overview
Explore the profile of Jacinda Tran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saldarriaga E, Hauber B, Barthold D, Brah A, Tran J, Marconi V, et al.
BMC Infect Dis
. 2025 Feb;
25(1):237.
PMID: 39972307
Background: Long-acting antiretroviral therapy (LA-ART) is an emerging alternative to daily oral ART pills that may improve HIV treatment adherence. We studied preference heterogeneity for LA-ART among people with HIV...
2.
Tran J, Mishra A, Zimmermann M, Hansen R
J Am Pharm Assoc (2003)
. 2024 Oct;
65(2):102274.
PMID: 39461720
Background: Pre-exposure prophylaxis (PrEP) is key to ending the US HIV epidemic, but uptake remains low. Federal legislation permitting community pharmacists to initiate PrEP nationwide could expand access to PrEP...
3.
Reinisch W, Melmed G, Nakase H, Seidelin J, Ma C, Xuan S, et al.
Adv Ther
. 2024 Aug;
41(10):3832-3849.
PMID: 39126596
Introduction: Evidence on the comparative efficacy and safety of approved therapies for ulcerative colitis (UC) during induction and maintenance, including upadacitinib (UPA), vedolizumab (VEDO), ustekinumab (UST), and tofacitinib (TOFA), is...
4.
Tran J, Hathaway C, Broshkevitch C, Palanee-Phillips T, Barnabas R, Rao D, et al.
Front Oncol
. 2024 May;
14:1382599.
PMID: 38720798
Introduction: Women living with human immunodeficiency virus (WLHIV) face elevated risks of human papillomavirus (HPV) acquisition and cervical cancer (CC). Coverage of CC screening and treatment remains low in low-and-middle-income...
5.
Kaggiah A, Maina C, Kinuthia J, Barthold D, Hauber B, Tran J, et al.
BMC Infect Dis
. 2024 Apr;
24(1):415.
PMID: 38641565
Background: In 2020, 14% of diagnosed persons living with HIV (PLWH) in Kenya were not taking antiretroviral therapy (ART), and 19% of those on ART had unsuppressed viral loads. Long-acting...
6.
Danese S, Tran J, DHaens G, Rubin D, Aoyama N, Zhou W, et al.
Inflamm Bowel Dis
. 2023 Feb;
29(11):1723-1729.
PMID: 36790041
Background: This post hoc analysis of a large, phase 3 program evaluated the effects of upadacitinib on fatigue, bowel urgency, and abdominal pain in patients with moderately to severely active...
7.
Panes J, Loftus E, Higgins P, Lindsay J, Zhou W, Yao X, et al.
Inflamm Bowel Dis
. 2023 Jan;
29(9):1421-1430.
PMID: 36645051
Background: We evaluated the health-related quality of life (HRQoL) benefits of upadacitinib (UPA) induction and maintenance treatment in a phase 3 study of patients with ulcerative colitis (UC) across a...